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Axon degeneration is a prominent feature of various neurodegenerative diseases, such
as Parkinson’s and Alzheimer’s, and is often characterized by aberrant mitochondrial
dynamics. Mitochondrial fission, fusion, and motility have been shown to be particularly
important in progressive neurodegeneration. Thus we investigated these imperative
dynamics, as well as mitochondrial fragmentation in vincristine induced axon degradation
in cultured dorsal root ganglia (DRG) neurons. CytNmnat1 inhibits axon degeneration
in various paradigms including vincristine toxicity. The mechanism of its protection is
not yet fully understood; therefore, we also investigated the effect of cytNmnat1 on
mitochondrial dynamics in vincristine treated neurons. We observed that vincristine
treatment decreases the rate of mitochondrial fission, fusion and motility and
induces mitochondrial fragmentation. These mitochondrial events precede visible axon
degeneration. Overexpression of cytNmnat1 inhibits axon degeneration and preserves
the normal mitochondrial dynamics and motility in vincristine treated neurons. We
suggest the alterations in mitochondrial structure and dynamics are early events which
lead to axon degeneration and cytNmnat1 blocks axon degeneration by halting the
vincristine induced changes to mitochondrial structure and dynamics.
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INTRODUCTION
In addition to providing the largest sources of cellular ATP, mitochondria are intimately involved
in the regulation of intracellular calcium levels and pH, they serve as oxygen sensors, and
are the source of super-oxide radicals (Müller et al., 2005). Current views of mitochondrial
dynamics have disproven the traditional notion of singular, randomly dispersed organelles
and it is now accepted that mitochondria constitute a population of organelles that are
actively transported through the cell, fuse, divide, and undergo regulated turnover (Nunnari
et al., 1997; Dedov and Roufogalis, 1999; Chen and Chan, 2005, 2009). Because of these
dynamic processes, mitochondria are able to respond to cellular demands, influence cytosolic
communication and signaling cascades, be moved to critical subcellular compartments, and finally,
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assess and respond to mitochondrial fitness (Chen and Chan,
2009). Within the past decade, studies have highlighted the
impetus of mitochondrial dynamics in maintaining integral
cell and animal physiological processes, influencing function,
differentiation, and ultimately affecting survival (Chen and
Chan, 2005, 2009). More specifically mis-regulated dynamics-
mitochondrial fission and fusion- have been shown to increase
reactive oxygen species (ROS), decrease ATP production, as well
as detrimentally alter apoptosis (Liesa et al., 2009; Martin, 2012)
and mitophagy (Rambold et al., 2011; Shen et al., 2014). These
deficits are also associated with numerous neurodegenerative
disorders including Parkinson’s, Alzheimer’s, Charcot-Marie
Tooth, Amyotrophic Lateral Sclerosis, and Huntington’s diseases
(Wang et al., 2005; Press and Milbrandt, 2008; Chen and
Chan, 2009; Vohra et al., 2010; Wen et al., 2011; Martin, 2012;
Alobuia et al., 2013; Korobova et al., 2013).
Typically preceding clinical symptoms, axonal degeneration
is a prominent feature of peripheral neuropathies and
neurodegenerative disorders. Wallerian degeneration, a
self-destructive process at the distal portion of transected
axons, has proven to be a useful model for studying the
mechanism of axon degeneration (Wang et al., 2005). Having
been shown to occur without activating the caspase family
of cysteine proteases, Wallerian degeneration is described
as being mechanistically different from neuronal apoptosis
triggered by nerve growth factor (NGF) deprivation (Wang
et al., 2005; Press and Milbrandt, 2008; Vohra et al., 2010;
Wen et al., 2011). Insight into the mechanism of Wallerian
degeneration came from a spontaneously occurring mutant
mouse strain whose axons survived for weeks post-transection
due to the overexpression of a fusion protein (WldS) containing
full length nicotinamide mononucleotide adenylyl transferase1
(Nmnat1; Wang et al., 2005). Further investigation revealed that
overexpression of Nmnat1, an enzyme required for nicotinamide
adenine dinucleotide (NAD+) biosynthesis, alone can prevent
axon degeneration from physical and chemical triggers (Wang
et al., 2005). Catalyzing a key step in NAD+ synthesis, Nmnat1
plays an evolutionarily conserved role in neuronal maintenance
(Sasaki et al., 2009). Although overexpression of Nmnat1 does
not increase the level of NAD+ in the neurons, it has been
shown to reduce the loss of NAD+ in transected axons (Wang
et al., 2005; Sasaki et al., 2009). NAD+ depletion in transected
neurons is decreased in parallel with ATP levels supporting the
notion that Nmnat1 acts through local bioenergetics pathways in
transected axons (Wang et al., 2005; Press and Milbrandt, 2008;
Vohra et al., 2010; Wen et al., 2011).
Mitochondria are implicated in neurodegeneration (Martin,
2012), for example mitochondrial depolarization induces axon
degeneration that is independent of classical cell death pathways
(Gerdts et al., 2013). Interestingly this form of degeneration can
be prevented by depletion of Sarm1 (SARM, sterile α-motif-
containing and armadillo-motif containing protein) (Araki et al.,
2004; Gerdts et al., 2013; Summers et al., 2014). Additionally,
Nmnat1 overexpression prevents axon degeneration induced by
mitochondrial toxins (Press and Milbrandt, 2008). Recent work
has demonstrated that loss of mitochondrial dynamics prevent
mitophagy which is linked to neurodegeneration in mice (Twig
et al., 2008; Chen et al., 2015). Finally it has been indicated that
activation of the mitochondrial transition pore (mPTP) is a key
regulator of axonal degeneration (Barrientos et al., 2011).
At this time the role of mitochondria in neurodegeneration
is not completely understood especially the role mitochondrial
dynamics may play. Thus we investigated the relationship
of mitochondrial dynamics in vincristine induced axon
degeneration and Nmnat1 mediated axonal protection. We
analyzed mitochondrial dynamics in cultured dorsal root
ganglia (DRG) neurons overexpressing cytNmnat1 and treated
with vincristine. Vincristine, an anti-cancer drug, is a known
stabilizer of microtubules and has been shown to cause
peripheral neurotoxicity, likely through alteration of calcium
and ATP levels (Canta et al., 2015). The effect of cytNmnat1
overexpression on the rates of mitochondrial fission, fusion,
motility, and mitochondrial fragmentation was assessed utilizing
confocal laser microscopy at time points associated with axon
degeneration—as elucidated from previous studies (Press and
Milbrandt, 2008; Vohra et al., 2010; Wen et al., 2011). Our results
indicate that during the process of neuronal degeneration,
induced by vincristine, fission, fusion and motility rates were
decreased and the mitochondria fragmented. More importantly,
we show that the neuroprotective protein, cytNmnat1
significantly prevented the alteration of mitochondrial fission,
fusion and fragmentation. Most interesting is that our work
suggests these alterations occur prior to significant deterioration
of the axon.
MATERIALS AND METHODS
DRG Culture
This study was carried out in accordance with the
recommendations of PHS Policy on Humane Care and Use
of Laboratory Animals, the Guide for the Care and Use of
Laboratory Animals, and the policies and procedures of the
University of Central Arkansas. The protocol was approved by
the UCA Animal Care and Use committee.
Mouse DRG were collected from embryonic day 12.5 (E12.5)
CD1 mice embryos. The DRGs from 5 embryos (∼200 total
DRGs) of CD1mice were dissociated and resuspended in 50µl of
Neurobasal media (Invitrogen) containing 2% B27 (Invitrogen)
and 50 ng/ml NGF (Harlan Bioproducts) per dissected embryo.
Suspended DRG neurons were placed as a drop (2 µl) near one
end of each well in Lab TekII 4-well chambered cover glass
(Nalge Nunc International), which had been previously coated
with poly-D-lysine (0.1 mg/ml) and laminin (2–5 ug/ml). The
chambered cover glass was then incubated at 37◦C at 5% CO2 for
15 min before 500 µl of Neurobasal media containing 2% B27,
50 ng/ml NGF, 1 µm 5-fluro-2′-deoxyuridine (Sigma), and 1µm
uridine (Sigma) was added to each well.
Vincristine (0.4 µM) was added to 14 days in vitro (DIV)
cultures to induce axon degeneration.
Lentiviral Infection of DRG Neurons
Lentiviruses were generated as previously described (Araki
et al., 2004). DRG neurons were infected with lentiviruses
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expressing Ds-Red Mito to track mitochondria and GFP-
cytNmnat1 (105–106 infectious units in 1 DIV neurons)
(Baloh et al., 2007; Vohra et al., 2010). Control cells were
infected with lentivirus expressing Ds-Red Mito and
EGFP-only vector. Virus-containing medium was replaced
with fresh media at 2 DIV and gene expression was
verified via fluorescent microscopy of the EGFP or Ds Red
reporter.
Quantification of Mitochondrial Fission
and Fusion in E12.5 CD-1 Mouse DRGs
A Zeiss laser scanning LSM Pascal confocal microscope with
40 × and 63 × objective lenses was used to visualize 0.50 µm
thick optical slices of DRG axons with a single plane imaged every
2.97 s for 180 s or until bleaching occurred. Fluorescent images
as well as bright field images were collected.
An organelle splitting into two separate entities and
remaining that way for the next couple of frames was classified as
a fission event. Fusion events were identified when two organelles
approached each other, connected, and remained that way for
the next couple of frames (Schimmel et al., 2012). To ensure
accurate quantification, two approaching organelles, appearing
to undergo fusion, which appeared in subsequent frames to have
passed by each other—returning to a similar arrangement as in
the preceding frames—were not counted as an event; similar
precautions were taken when identifying fission events where an
organelle that appeared to split into separate organelles only to
return to its original conformation in the subsequent frames was
not counted.
Rates of fission and fusion were calculated by taking the
average number of events/min for each time point at each
condition and presented as a mean ± the standard error.
Statistical analysis was conducted utilizing Graph Pad Prism
version 6.07 and analyzed via non-parametric Kruskal-Wallis
with Dunn’s post hoc. Statistics generated are from embryos from
at least two independent litters, collected on at least two different
occasions, except for 96 h, litters were only collected once (3–5
images were collected for each condition/litter), p-values less
than 0.05 were considered statistically significant.
Quantifying Mitochondrial Fragmentation
in E12.5 CD-1 Mouse DRGs
Zeiss LSM browser was utilized to take a single frame out
of two movies from each time point. The lengths and widths
of 30 mitochondria were measured under each condition.
Fragmentation was determined by the average length to width
assessment of the organelles.
Statistical analysis was conducted utilizing a non-parametric
multiple comparisons Wilcoxon analysis by JMP statistical
analysis software (SAS Institute, Inc.) to compare the
measurements from each condition and time point with
p-values less than 0.05 being considered statistically significant.
Comparison of treatments to control at 96 h was carried out in
Graph Pad Prism version 6.07 via 1-way ANOVA, Holm-Sidak’s
multiple comparisons test.
Quantifying Mitochondrial Motility in E12.5
CD-1 Mouse DRGs
Kymographs were generated using ImageJ from the single plane
time lapse confocal images collected as described above. A region
of interest (ROI) was selected in three different areas in the
first image of each series, for a minimum of 15 kymographs
(approximately 60 mitochondria) for each condition. The
ROIs were approximately the same width and length in each
instance. The ROIs were converted, stacked, and used to create
kymographs, which depict mitochondrial movement specific to
the selected ROI. To quantify motility, mitochondrial movement
in the kymograph was traced with a line where the slope of the
line represents velocity in pixels/time point. These velocities were
converted to µm/s.
Statistical analysis was conducted by utilizing Graph Pad
Prism version 6.07 to compare velocity measurements within
each treatment and across time points with p-values less than 0.05
being considered statistically significant. Rates were analyzed via
non-parametric Kruskal-Wallis with Dunn’s post hoc.
Scoring Degeneration of Axons
Single frames from every video acquired, as described above,
were analyzed for neurodegeneration. A minimum of 50 axons
were quantified for all treatments except cytNmnat1 96 h treated
axons which only had 32 distinguishable axons. Each axon was
classified based on degeneration into five categories and assigned
a value between 1 and 5 (adapted from Fang et al., 2014). Axons
classified as 5 were fully intact with smooth membrane along
the length of the axon (Figure 4B left column). Category 4 were
intact axons that had 21–40% of its membrane beginning to
bleb (Figure 4B vincristine 24 h frame). Axons that scored a 3
were 41–60% degenerated; these were still intact, had not begun
fragmenting, but had extensive blebbing (Figure 4B vincristine
48 h frame). The fourth category, which was assigned a value of
2, were 61–80% degenerated; these axons had begun fragmenting
in addition to extensive blebbing of the membranes (Figure 4B
vincristine 48 h). Please note: vincristine 48 h treatment images
consistently contained both category 2 and category 3 axons. The
final category, valued as a 1, were 100% degenerated axons, in
these images it was not possible to identify the original number of
axons (Figure 4B bottom frame of middle column). Each image
was given a score by multiplying the number of axons that fell
into each category (i.e., 5 axons in category 5 so 5 × 5 = 25;
2 axons in category 1 so 2 × 1 = 2) followed by these values
being added together (i.e., 25 + 2 = 27). For each treatment the
image scores were averaged and a two-way ANOVAwith post hoc
Tukey test in Graph Pad Prism version 6.07 was performed.
RESULTS
Overexpression of cytNmnat1 in DRGs
Maintains Rates of Mitochondrial Fission
and Fusion in the Presence of Vincristine,
an Inducer of Neurodegeneration
To determine the effect of vincristine induced axon degeneration
and cytNmnat1 on mitochondrial fission and fusion, axons
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TABLE 1 | Rates of fission and fusion in axons treated with vincristine
(events/min).
24 h 48 h 96 h
cytNmnat1 Fission 1.202 ± 0.216 1.049 ± 0.215 0.750 ± 0.226
Fusion 1.219 ± 0.286 1.136 ± 0.164 1.158 ± 0.413
Vincristine Fission 0.497 ± 0.117 0.029 ± 0.029 0.000 ± 0.000
Fusion 0.387 ± 0.111 0.115 ± 0.064 0.000 ± 0.000
cytNmnat1 Fission 0.557 ± 0.135 0.389 ± 0.151 0.509 ± 0.195
+ vincristine Fusion 0.400 ± 0.136 0.286 ± 0.093 0.390 ± 0.119
were imaged at different time points and the rates of
fission and fusion were quantified. Mitochondrial fission rates
decreased in the axons of 24 h vincristine treated neurons by
59% compared to cytNmnat1 expressing cultures (Table 1).
Similarly, mitochondrial fusion rates also decreased in the
axons of vincristine treated neurons by 68% as compared to
the cytNmnat1 expressing cells (Table 1). These events were
undetectable after 96 h of vincristine treatment (Figure 1,
Table 1).
To determine if cytNmnat1 will prevent the vincristine
induced loss of fission and fusion, rates in vincristine treated
axons were compared to rates of fission and fusion in axons
overexpressing cytNmnat1 and exposed to vincristine. By 48 h of
treatment, fission and fusion rates are recovering; the expression
FIGURE 1 | The average rates of mitochondrial fission and fusion in
axons of dorsal root ganglion neuronal cultures at 96 h. Cultures were
either untreated, overexpressed the protective protein GFP-cytNmnat1,
treated with 0.4 µM vincristine, or overexpressed GFP-cytNmnat1 and treated
with vincristine. The overexpression of cytNmnat1 recovered the fission and
fusion processes inhibited by vincristine (p < 0.05). ∗ Indicate significance.
of cytNmnat1 increased these rates by 93% and 60%, respectively,
as compared to the axons of vincristine treated neurons (Table 1).
This trend shows significant protection by 96 h for both fission
and fusion (p < 0.05, Figure 1, Table 1). In conclusion, the
overexpression of cytNmnat1 recovered the fission and fusion
processes in the axons inhibited by vincristine, maintaining the
rates at cytNmnat1 expressing culture levels by 96 h.
cytNmnat1 Overexpression Inhibits
Mitochondrial Fragmentation
In order to assess cytNmnat1’s effect on mitochondrial
fragmentation the length and width of 30 mitochondria from
each time point were measured in the axons of DRG neuronal
cultures that were overexpressing cytNmnat1, incubated with
vincristine alone, or overexpressing cytNmnat1 + vincristine.
As expected, vincristine treatment fragmented the
mitochondria as measured by decreased length and increased
width resulting in more circular or round mitochondria
(p < 0.05, Figure 2). In axons overexpressing cytNmnat1, the
total mitochondrial length and width were relatively stable over
time, though they did get shorter (p< 0.05, Figure 2), indicating
that the organelles remain filamentous overtime with cytNmnat1
overexpression. Finally, axons treated with overexpressed
cytNmnat1 + vincristine were statistically similar to cells only
overexpressing cytNmnat1, thus cytNmnat1 protects the cells
from the vincristine induced mitochondrial fragmentation
(p < 0.05, Figure 2). It is interesting to note that mitochondria
are larger-both in length and width- in the untreated axons
(p< 0.05, Figure 2).
Mitochondrial Motility is Partially
Maintained when Neurodegeneration
is Prevented by cytNmnat1
The final aspect of mitochondrial dynamics that we studied is
velocity of organelle movement by analyzing kymographs
from the three treatments. Treatment with vincristine
shows a trend of decreasing mitochondrial movement from
0.132 ± 0.234 µm/s at 24 h vincristine treatment to no
movement at all by 96 h (Table 2). We show that mitochondria
move an average of 0.191 ± 0.088 µm/s when cytNmnat1
is overexpressed for 24 h, this rate is relatively stable out
to 96 h (Table 2). Overexpression of cytNmnat1 does
protect from the vincristine defect bringing velocities back
up to 0.083 ± 0.015 µm/s by 96 h treatment, though not
up to the level of cytNmnat1 expressing axons (Figure 3,
Table 2).
In summary, vincristine treatment significantly alters all
measured mitochondrial parameters and cytNmnat1 expression
significantly counteracts fission, fusion, and fragmentation
changes in the axons of vincristine treated neurons.
Vincristine Alters Mitochondrial Dynamics
Prior to Visible Axon Degeneration
Thus far, we have shown that cytNmnat1 overexpression, which
is known to protect axons from degeneration, significantly
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FIGURE 2 | The length and width of mitochondria for each treatment condition of dorsal root ganglion neuronal cultures over time. (A) Graph
representing the average mitochondrial length for each treatment over time. (B) Graph representing the average mitochondrial width for each treatment over time.
The mitochondrial length decreased in correlation with an increase in the mitochondrial width in vincristine only treated cells, indicating an increase in fragmentation.
The data indicate that overexpression of cytNmnat1 preserves mitochondrial morphology when axon degeneration has been initiated by vincristine (p < 0.05). For
simplicity only significance between treatments, not over time, is shown. (C) Representative mitochondrial images showing elongated, short, and round or
fragmented organelles. In general mitochondria with overexpressed cytNmnat1 are elongated but do get shorter over time, while vincristine treated mitochondria
become round and fragmented. Scale bar is equivalent to 10 µm. ∗ Indicate significance.
prevents the alteration of mitochondrial dynamics as well. In an
effort to understand more about the process of vincristine
induced neurodegeneration, we assessed degeneration
over time to determine which takes place first, the axonal
morphological changes or the changes in mitochondrial
dynamics. Our results indicate that degeneration of the
axons induced by vincristine was detectible by 24 h but was
not significantly different from cytNmnat1 or cytNmnat1 +
vincristine treatments until 96 h (F(2,75) = 11.4 p < 0.0001,
Figure 4). As expected, throughout the time course there
TABLE 2 | Velocity of mitochondria in axons treated with vincristine and
cytNmnat1 (µm/s).
24 h 48 h 96 h
cytNmnat1 0.191 ± 0.088 0.168 ± 0.118 0.179 ± 0.057
Vincristine 0.132 ± 0.234 0.011 ± 0.02 0
cytNmnat1 + vincristine 0.066 ± 0.033 0.108 ± 0.039 0.083 ± 0.015
was no difference between the cytNmnat1 overexpressing
axons and the cytNmnat1 overexpressing plus vincristine
treatment.
Mitochondrial fission and fusion are significantly decreased
by 24 h (Fission: p < 0.0116, Fusion: p < 0.0123, Table 1)
while fragmentation in these degenerating neurons was apparent
by 48 h when compared to cytNmnat1 overexpressed cells
(p < 0.0004), (Figure 2). From these results we can conclude
that vincristine treatment causes a decrease in fission and fusion,
followed by mitochondrial fragmentation, then visible axon
degeneration.
DISCUSSION
Axon degeneration, a hallmark of many neurodegenerative
diseases, has been found to occur prior to clinical manifestation
of symptoms and has been linked to mitochondrial dysfunction
in a number of instances (Press and Milbrandt, 2008;
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FIGURE 3 | Mitochondrial velocity for each treatment condition.
(A) Representative kymographs of mitochondria under each treatment.
(B) Graph representing the average mitochondrial velocity at 96 h post
treatment. The overexpression of cytNmnat1 in vincristine treated cells allows
the mitochondria to partially regain motility as compared to vincristine
treatment alone. ∗ Indicate significance.
Vohra et al., 2010). Elucidating the mechanism of axon
degeneration, especially as it relates to mitochondrial
dysfunction in neurodegeneration, can lead to preventative
and therapeutic measures against such debilitating afflictions.
Recent work has indicated that axon degeneration is an
active but apoptosis-independent mechanism (Vohra
et al., 2010; Gerdts et al., 2013). However, mitochondrial
involvement in the form of opening of mitochondrial
permeability transition pores and mitochondrial Sarm1 is
implicated in axon degeneration (Barrientos et al., 2011).
Furthermore, abnormal mitochondrial dynamics and altered
mitochondrial motility is implicated in synaptic degeneration
in the mouse models of Alzheimer’s disease (Calkins
et al., 2011). In the present investigation we analyzed the
relationship between mitochondria dynamics, morphology and
neurodegeneration.
FIGURE 4 | Degeneration of axons over time. Axons were assigned a
score (see “Materials and Methods” Section) based on their degeneration
status. (A) Graph of degeneration for each treatment. Vincristine treated axons
were degenerated by 96 h, which overexpression of cytNmnat1 prevented
(p < 0.0001). # A significant difference when compared to all means,
∗ a significant difference between the paired columns. (B) Representative
images for each treatment. Fully intact axons are found in all cytNmnat1
treatments. Vincristine treated axons for 24 h typically showed intact axons
with blebbing beginning to occur. Extensive blebbing and axon fragmentation
can be seen in 48 h vincristine treatments, whereas fully degenerated axons
are found in 96 h vincristine treatment. More than 100 axons were analyzed
for each treatment except for: 96 h cytNmnat1 overexpression and 96 h
cytNmnat1 + vincristine, 30 and 50 axons respectively were quantified.
As expected, we show that vincristine fragments
the mitochondria and decreases mitochondrial motility
(Avery et al., 2012; Kitay et al., 2013). We also show that
vincristine significantly disrupts mitochondrial fission and
fusion. This is most likely because loss of microtubules -induced
by vincristine- drastically reduces mitochondrial dynamics, most
recently shown in Woods et al. (2016).
To try and understand the mechanism of neurodegeneration,
we furthered our analysis by looking at the protective effect
of cytNmnat1 on mitochondrial dynamics and morphology
after vincristine induced neurodegeneration. Nmnat protects
axons against various insults but its protective mechanism is
still obscure. Nmnat protects axons in conditions of rotenone
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toxicity and blocks the ROS production in rotenone treated
neurons (Press and Milbrandt, 2008). Nmnat overexpression
also prevents the depletion of axonal NAD+ and maintains the
levels of ATP in the transected axons (Wang et al., 2005; Press
and Milbrandt, 2008; Vohra et al., 2010; Wen et al., 2011),
thus suggesting that mitochondrial function may be influenced
by the overexpression of Nmnat. Here we demonstrate that
cytNmnat1 can prevent the loss of fission and fusion due
to vincristine. We and others also show that various forms
of Nmnat recover mitochondrial motility after induction of
neurodegeneration, though not always significantly (Avery et al.,
2012). It has also been demonstrated that this mitochondrial
transport is required for Nmnat’s protective activity (Avery
et al., 2012; Fang et al., 2014). Similar types of deficits in
axonal mitochondrial motility have been observed in axon
degeneration induced by: expression of the human mitofusion2
(Mfn2) mutant protein in the cultured DRG neurons (Baloh
et al., 2007; Misko et al., 2010), hydrogen peroxide exposure and
oxygen-glucose deprivation in primary hippocampal cultures
(Fang et al., 2014). Cagalinec et al. (2013) also observed
decreased motility, fission, and fusion in neurodegeneration
disease models involving Huntingtin and Tau. Additionally, our
work and that of Kitay et al. (2013) indicates that cytNmnat1
prevents mitochondrial fragmentation. The direct reason for
mitochondrial fragmentation during neuron degeneration is
unclear, but it is likely a result of the combined decrease in
mitochondrial fission, fusion and motility.
Finally, the work presented here suggests that the decrease
in fission, fusion, motility, and mitochondrial fragmentation
occur prior to the axon’s morphological changes when treated
with vincristine. Barrientos et al. (2011) also showed that
mitochondrial swelling precedes neurodegeneration, supporting
our study.
Are mitochondrial dynamics directly involved in axon
degeneration? It is well established that mitochondrial function
is controlled by proper morphology and distribution (Nunnari
and Suomalainen, 2012) and that morphology and distribution
is maintained by mitochondrial dynamics (Nunnari et al.,
1997; Bleazard et al., 1999; Karbowski and Youle, 2003; Twig
and Shirihai, 2011; El Zawily et al., 2014). The literature
demonstrates that mitochondrial dynamics are involved in the
regulation of autophagy; more specifically mutations in PINK
(which cause parkinsonism and mis-regulate autophagy) induce
fragmentation of the mitochondria through a block in fusion.
Additionally, work on the mitochondrial motility protein -Miro-
has signified that it is a substrate of PINK/parkin thus autophagy
will also prevent mitochondrial motility. Thus, the loss of fission,
fusion, and motility may inhibit mitochondrial function, and
stimulate mitophagy.
Additionally, Wallerian degeneration is induced by a
calcium overload (Wang et al., 2012) that likely activates
the mitochondrial permeability transition pore (Barrientos
et al., 2011). Therefore, we suggest calcium overload decreases
mitochondrial dynamics (fission, fusion, and motility), inducing
fragmentation and subsequently, mitochondrial function,
leading to mitophagy and neurodegeneration. Avery et al. (2012)
also showed something similar, demonstrating that axotomy
induces a calcium overload, while WldS prevents this overload,
maintains permeability resistance and mitochondrial motility.
Future experiments need to focus on mitochondrial dynamics
under calcium overload conditions, and neurodegeneration
measurements with Mdivi-1 treatment. Mdivi-1 is an inhibitor
of DRPs the regulators of mitochondrial fission and fusion. It
must also be stated that the work presented here only begins
to look at the role of mitochondria in neurodegeneration-
specifically studying mitochondrial dynamics. At this time
cytochrome c release, change in membrane potential, and the
induction of apoptosis were not determined, though these are
important future experiments to definitively identify the role of
mitochondria in degeneration.
In conclusion, we propose that vincristine induced
axon degeneration is triggered/propagated by decreased
mitochondrial dynamics and fragmentation, and that
cytNmnat1 inhibits axonal degeneration by preserving normal
mitochondrial integrity and dynamics.
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